Skip to main content
. 2024 Feb 26;20:151–160. doi: 10.2147/TCRM.S448090

Table 3.

Geometric Mean Ratio and Its 90% Confidence Interval Between Only Escitalopram Administration and Co-Administration of Escitalopram with Herbal Medicine Stratified by CYP2C19 Phenotype

Group Treatment CYP2C19 Phenotype Parameters GeoLSM GMR (90% CI)
E E+A1 E+A1/E
1 E vs E+A1 (n=8) EM Cmax,ss (ng/mL) 21.46 22.69 1.0574 (0.7600–1.4712)
AUCtau,ss (h∙ng/mL) 346.88 355.48 1.0248 (0.6766–1.5522)
IM Cmax,ss (ng/mL) 23.27 27.95 1.2013 (0.9634–1.4980)
AUCtau,ss (h∙ng/mL) 413.40 453.75 1.0976 (0.8441–1.4273)
E vs E+A2 (n=6*) E E+A2 E+A2/E
EM Cmax,ss (ng/mL) 21.46 21.38 0.9966 (0.6958–1.4276)
AUCtau,ss (h∙ng/mL) 346.88 334.68 0.9648 (0.6256–1.4880)
IM Cmax,ss (ng/mL) 25.86 26.92 1.0413 (0.6321–1.7153)
AUCtau,ss (h∙ng/mL) 439.45 483.71 1.1007 (0.6499–1.8641)
2 E vs E+A3 (n=9) E E+A3 E+A3/E
EM Cmax,ss (ng/mL) 23.00 24.09 1.0476 (0.7043–1.5583)
AUCtau,ss (h∙ng/mL) 353.64 374.10 1.0579 (0.6698–1.6708)
IM Cmax,ss (ng/mL) 20.63 25.14 1.2185 (0.8163–1.8190)
AUCtau,ss (h∙ng/mL) 330.42 402.84 1.2192 (0.7626–1.9490)
E vs E+A4 (n=9) E E+A4 E+A4/E
EM Cmax,ss (ng/mL) 23.00 24.65 1.0719 (0.6959–1.6513)
AUCtau,ss (h∙ng/mL) 353.64 393.18 1.1118 (0.6971–1.7731)
IM Cmax,ss (ng/mL) 20.63 24.73 1.1983 (0.7699–1.8651)
AUCtau,ss (h∙ng/mL) 330.42 388.63 1.1762 (0.7260–1.9055)

Notes: *Two participants in Group 1 were excluded after the completion of period 2. One participant in Group 1 was a PM.

Abbreviations: E, 10 mg tablet of escitalopram orally once in fasting; E+A1, 10 mg tablet of escitalopram orally once daily with Gami-soyosan, one packet thrice a day for 7 d; E+A2, 10 mg tablet of escitalopram orally once daily with Banhasasim-tang, one packet thrice a day for 7 d; E+A3, 10 mg tablet of escitalopram orally once daily with Ojeok-san, one packet thrice a day for 7 d; E+A4, 10 mg tablet of escitalopram orally once daily with Bojungikgi-tang, one packet thrice a day for 7 d; GeoLSM, geometric least squares mean; GMR, geometric least squares mean ratio; CI, confidence interval; Cmax,ss, maximum plasma concentration at steady state; AUCtau,ss, area under the plasma drug concentration–time curve over a dosing interval at steady state.